Fermenta Biotech Limited

FERMENTA

INE225B01021

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:12:40 2024-05-18 EDT			5-day change	1st Jan Change
162.8 ^INR	0.00%		+1.94%	+0.77%

02-15	Fermenta Biotech Sells Premises in Thane, India for INR136 Million	MT
02-12	Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited for Rs 138.85 million.

January 16, 2023

Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited (BSE:506414) for Rs 138.85 million on January 17, 2023.

Red Brick It Support Services LLP completed the acquisition of premises in Thane One Building from Fermenta Biotech Limited (BSE:506414) for Rs 138.85 million on January 17, 2023.

Latest news about Fermenta Biotech Limited

Fermenta Biotech Sells Premises in Thane, India for INR136 Million	02-15	MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Fermenta Biotech Sells Land in Pune, India for INR448 Million	12-05	MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB; Outlook Negative	11-16	MT
Fermenta Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
Fermenta Biotech Limited Approves Dividend for the Financial Year Ended March 31, 2023, Payable on or Before October 10, 2023	23-09-29	CI
Fermenta Biotech Opens Premix Plant in Kullu, India	23-09-07	MT
Fermenta Biotech Limited Announces Inauguration of Customized Premix Manufacturing Plant in Kullu, Himachal Pradesh	23-09-07	CI
Fermenta Biotech Resumes Full Operations of Kullu Plant in Himachal Pradesh, India	23-08-13	MT
Fermenta Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Fermenta Biotech Resumes Partial Operations at Himachal Pradesh, India Facility	23-07-23	MT
Fermenta Biotech Halts Operations at Himachal Pradesh, India Facility Due to Heavy Rain	23-07-11	MT
Fermenta Biotech Limited Announces Suspension of Operations Due to Heavy Rainfall in Himachal Pradesh	23-07-11	CI
Fermenta Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29	CI
Fermenta Biotech Limited Recommends Final Equity Dividend for the Financial Year Ended March 31, 2023	23-05-29	CI
Fermenta Biotech Sells Premises in Thane, India for INR66 Million	23-05-25	MT
Fermenta Biotech Sells Property in Maharashtra, India for INR140.5 Million	23-05-17	MT
Fermenta Biotech Sells Company Premises in Thane, India for INR140 Million	23-05-16	MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB+; Revises Outlook to Negative	23-04-07	MT
Fermenta Biotech Signs Pact to Sell Premises in Thane, India for INR140 Million	23-03-30	MT
Fermenta Biotech Sells Property in Maharashtra, India for INR 116 Million	23-03-21	MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Fermenta Biotech Sells Property in Maharashtra, India for INR139 Million	23-01-17	MT
Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited for Rs 138.85 million.	23-01-16	CI

Chart Fermenta Biotech Limited

Duration

Period

More charts

Company Profile

Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. The Company's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The Company has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The Company provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.

Sector

Pharmaceuticals

Calendar

2024-05-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
FERMENTA BIOTECH LIMITED	+0.77%	56.45M
CSL LIMITED	-3.05%	90.45B
SAMSUNG BIOLOGICS CO.,LTD.	+3.68%	41.45B
BIOGEN INC.	-10.95%	33.57B
UCB	+60.01%	25.73B
BIOMARIN PHARMACEUTICAL INC.	-20.19%	14.73B
INCYTE CORPORATION	-9.06%	12.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.46%	11.7B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.53%	11.44B
SWEDISH ORPHAN BIOVITRUM AB	+5.02%	8.79B

Biopharmaceuticals

Fermenta Biotech Limited

Equities

FERMENTA

INE225B01021

Pharmaceuticals

Red Brick It Support Services LLP acquired premises in Thane One Building from Fermenta Biotech Limited for Rs 138.85 million.

Latest news about Fermenta Biotech Limited

Chart Fermenta Biotech Limited

Company Profile

Income Statement Evolution

Quarterly revenue - Rate of surprise

Sector Biopharmaceuticals